IPO Details
| IPO Date | 22 to 24 Dec, 2025 |
| Listing Date | Tue, Dec 30, 2025 |
| Face Value | ₹ 2 per share |
| Price Band | ₹108 to ₹114 |
| Issue Price | ₹114 per share |
| Lot Size | 128 Shares |
| Sale Type | Fresh Capital |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE, NSE |
| Total Issue Size | 2,20,00,000 shares (agg. up to ₹ 251 Cr) |
| Share Holding Pre Issue | 5,68,43,250 shares |
| Share Holding Post Issue | 7,88,43,250 shares |
| BSE Script Code / NSE Symbol | 544666 / GKSL |
| ISIN | INE0V0W01025 |
IPO Subscription Details
| Anchor Investors | 1 |
| QIB (Ex Anchor) | 1.06 |
| Non-Institutional Buyers | 5.73 |
| bNII (bids above ₹10L) | 5.25 |
| sNII (bids below ₹10L) | 6.68 |
| Retail Investors | 19.04 |
| Total ** | 5.21 |
IPO Important Dates
| IPO Open | Mon, Dec 22, 2025 |
| IPO Close | Wed, Dec 24, 2025 |
| Allotment | Fri, Dec 26, 2025 |
| Refund | Mon, Dec 29, 2025 |
| Credit of Shares | Mon, Dec 29, 2025 |
| Listing | Tue, Dec 30, 2025 |
IPO Lot Size
| Retail (Min) | 1 | 128 | ₹14,592 |
| Retail (Max) | 13 | 1,664 | ₹1,89,696 |
| S-HNI (Min) | 14 | 1,792 | ₹2,04,288 |
| S-HNI (Max) | 68 | 8,704 | ₹9,92,256 |
| B-HNI (Min) | 69 | 8,832 | ₹10,06,848 |
Key Performance Indicator
| ROE | 36.61% |
| ROCE | 37.65% |
| Debt/Equity | 0.15 |
| RoNW | 36.61% |
| PAT Margin | 23.61% |
| EBITDA Margin | 41.12% |
| Price to Book Value | 22.62 |
Peers Comparison
| Yatharth Hospital & Trauma Care Services Limited | 14.72 | 14.83 | 88.05 | 55.84 | 8.13 | 9.34 |
| Gpt Healthcare Limited | 6.08 | 12.26 | 40.71 | 24.51 | 20.14 | 3.73 |
| Kmc Speciality Hospitals (india) Ltd | 1.31 | 9.25 | 23.16 | 52.60 | 13.04 | 3.00 |
| Gujarat Kidney & Super Speciality Limited | 1.85 | 1.85 | 5.04 | | 36.61 | |
Information about company
Incorporated in 2019, Gujarat Kidney and Super Speciality Limited (GKASSL) specializes in providing multispeciality healthcare services, including secondary and tertiary care, across multiple locations in Gujarat, India.
The company operates seven multispeciality hospitals and four pharmacies with a total bed capacity of 490 beds, an approved capacity of 455 beds, and an operational capacity of 340 beds.
The company's hospitals include Gujarat Kidney and Superspeciality Hospital (Vadodara), Gujarat Multispeciality Hospital (Godhra), Raj Palmland Hospital Private Limited (Bharuch), M/s. Surya Hospital and ICU (Borsad), Gujarat Surgical Hospital (Vadodara), and Ashwini Medical Centre (Anand). The company also operates Ashwini Medical Store (Anand).
Services:
Gujarat Superspeciality Hospital provides medical care in areas such as internal medicine, general surgery, minimally invasive procedures, orthopaedics and trauma treatment, joint replacement surgery, obstetrics and gynaecology, respiratory failure, non-interventional cardiology, diabetology, and anaesthesiology.
As of June 30, 2025, the company had 89 Doctors, 332 nurses and 338 other staff.
Competitive Strengths:
Objectives of IPO
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects: # Issue Objects Est Amt (₹ Cr.) 1 Proposed acquisition of Parekhs Hospital at Ahmedabad. 77.00 2 Part-payment of purchase consideration for the already acquired “Ashwini Medical Centre”. 12.40 3 Funding of capital expenditure requirements of the Company towards setting up of a new hospital in Vadodara. 30.10 4 Buying robotics equipment for our hospital Gujarat Kidney & Super Speciality hospital in Vadodara location. 6.83 5 Full or part repayment and/or prepayment of certain outstanding secured borrowings availed by the Company 1.20 6 Funding inorganic growth through unidentified acquisitions and General Corporate Purposes. 87.44 7 Acquisition of additional shareholding in the subsidiary namely “Harmony Medicare Private Limited” at Bharuch 10.78
Disclaimer
All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions.
We are not a SEBI Registered analyst. Readers must consult a qualified financial advisor prior to making any actual investment decisions, based on Information published on this application.
No financial information whatsoever published anywhere, within this application, should be considered as advice to buy or sell securities or invest in IPOs, or as a guide to doing so in any way whatsoever
Please read all Tearms and conditions , and agree to use the App
Day Wise Sub
| Dec 2
2, 2025 (Day 1) | 0.34 | 1.98 | 2.48 | 0.98 | 5.07 | 1.54 |
| Dec 2
3, 2025 (Day 2) | 0.34 | 2.97 | 3.18 | 2.54 | 10.70 | 2.72 |
| Dec 2
4, 2025 (Day 3) | 1.06 | 5.73 | 5.25 | 6.68 | 19.04 | 5.21 |
Day Wise GMP
| 30-12-2025 | 114.00 | 1.5(1.32%) | 115.5 |
| 29-12-2025 | 114.00 | 1.5(1.32%) | 115.5 |
| 28-12-2025 | 114.00 | 0(0.00%) | 114 |
| 27-12-2025 | 114.00 | 0(0.00%) | 114 |
| 26-12-2025 | 114.00 | 0(0.00%) | 114 |
| 25-12-2025 | 114.00 | 0(0.00%) | 114 |
| 24-12-2025 | 114.00 | 0(0.00%) | 114 |
| 23-12-2025 | 114.00 | 3.5(3.07%) | 117.5 |
| 22-12-2025 | 114.00 | 4(3.51%) | 118 |
| 21-12-2025 | 114.00 | 7(6.14%) | 121 |
| 20-12-2025 | 114.00 | 7(6.14%) | 121 |
| 19-12-2025 | 114.00 | 7(6.14%) | 121 |
| 18-12-2025 | 114.00 | 10(8.77%) | 124 |
| 17-12-2025 | 114.00 | 0(0.00%) | 114 |
| 16-12-2025 | 114.00 | 0(0.00%) | 114 |
| 15-12-2025 | | 0(%) | (%) |
IPO Reservation
| QIB Shares Offered | 1,65,00,000 (75.00%) |
| − Anchor Investor Shares Offered | 87,73,120 (39.88%) |
| − QIB (Ex. Anchor) Shares Offered | 77,26,880 (35.12%) |
| NII (HNI) Shares Offered | 33,00,000 (15.00%) |
| − bNII > ₹10L | 22,00,000 (10.00%) |
| − sNII < ₹10L | 11,00,000 (5.00%) |
| Retail Shares Offered | 22,00,000 (10.00%) |
| Total Shares Offered | 2,20,00,000 (100.00%) |
